Today: 11 June 2026
Exxon Mobil stock jumps in premarket on Venezuela headlines — what to watch before the bell
5 January 2026
1 min read

Exxon Mobil stock jumps in premarket on Venezuela headlines — what to watch before the bell

New York, January 5, 2026, 04:29 ET — Premarket

Exxon Mobil Corporation shares were up 3.2% at $126.55 in premarket trading on Monday, extending a burst of buying across U.S. oil majors as investors digested fast-moving headlines tied to Venezuela. Exxon traded between $126.26 and $127.38 in early extended-hours dealing; Chevron and ConocoPhillips were also sharply higher.

The moves matter because Venezuela sits atop the world’s largest proven crude reserves, and any shift in access — or U.S. policy — can quickly change expectations for future supply, sanctions risk and cash recoveries for companies that have battled Caracas for years.

For Exxon, the Venezuela angle is also legal and financial, not just barrels. A Reuters report said U.S. officials have told oil executives they would need to return and invest significant capital to revive Venezuela’s damaged oil sector if they want compensation tied to assets expropriated two decades ago — a high-stakes condition attached to any debt recovery.

Those claims trace back to arbitration, a dispute process that resolves cases outside court. ConocoPhillips has sought about $12 billion linked to Venezuela nationalizations, while Exxon has pursued $1.65 billion, Reuters reported.

“Exxon, Conoco and Chevron … are not going to be worried about investing in heavy oil,” Francisco Monaldi said, referring to the kind of crude produced in Venezuela’s Orinoco Belt. Reuters

The stock strength comes even as crude prices eased. Brent fell about 0.8% to $60.26 a barrel and U.S. West Texas Intermediate slid about 0.9% to $56.79, with ample global supplies offsetting the risk premium from Venezuela turmoil, Reuters reported.

Exxon closed the last regular session at $122.65 after touching an intraday high of $122.68, according to the company’s historical price data. Monday’s premarket pop lifts the stock well above that prior peak.

Technically, traders are watching whether Exxon holds above the prior 52-week ceiling near $122.68 — a level that can act as resistance when first breached — after premarket prints pushed well beyond it. MarketWatch lists Exxon’s 52-week range at $97.80 to $122.68.

But the Venezuela trade cuts both ways. Oil prices remain pressured by supply, Washington has said the embargo on Venezuelan crude stays in place, and any meaningful production recovery would take years and heavy investment — leaving room for a sharp fade if headlines cool or premarket liquidity thins out at the open.

Stock Market Today

  • Wall Street Gains on AI Stock Rally Amid Inflation and Middle East Tensions
    June 11, 2026, 11:16 AM EDT. Wall Street recovered some weekly losses Thursday as artificial intelligence (AI) stocks rebounded, led by chipmakers like Marvell Technology (+5.5%), Intel (+7.8%), and Applied Materials (+7.5%). The S&P 500 rose 0.5%, Dow Jones 0.7%, and Nasdaq 0.7%. Despite market gains, concerns about elevated AI valuations persist, while Oracle shares fell 11.1% after revealing plans to raise $40 billion to fund AI investments. Oil prices remained steady despite rising tensions in the Iran conflict, with Brent crude at $92.64 and U.S. crude at $90.29 per barrel. Meanwhile, wholesale inflation in the U.S. exceeded expectations in May, prompting the European Central Bank to raise interest rates, signaling global inflationary pressures.

Latest articles

S&P 500, Nasdaq, Dow edge higher as chip names catch a bid

S&P 500, Nasdaq, Dow edge higher as chip names catch a bid

11 June 2026
Oracle plunged 12.5% after projecting fiscal 2027 capital spending far above Wall Street estimates and planning to raise nearly $40 billion in debt and equity, dragging software stocks lower even as chipmakers fueled a partial tech rebound following Wednesday’s AI-led selloff, Reuters reported.
Theriva Biologics Pops on VCN-01 Study Results, Gets Traders’ Attention

Theriva Biologics Pops on VCN-01 Study Results, Gets Traders’ Attention

11 June 2026
TOVX soared 74.6% to $0.4252 after Theriva Biologics published Phase 1 VCN-01 data showing survival and biomarker signals in head-and-neck cancer, but the jump was not due to drug approval or revenue; investors face ongoing financing, dilution, and clinical-trial execution risks, with the company’s cash runway only into Q1 2027 and substantial doubt about its ability to continue as a going concern without new capital.
BAE Systems shares jump nearly 5% as Venezuela shock lifts European defense stocks
Previous Story

BAE Systems shares jump nearly 5% as Venezuela shock lifts European defense stocks

NuScale Power stock jumps 16% as House sets ‘New Nuclear Era’ hearing — what’s next for SMR
Next Story

NuScale Power stock jumps 16% as House sets ‘New Nuclear Era’ hearing — what’s next for SMR

Go toTop